Degradable removable implant for the sustained release of an active compound
AssigneeJanssen R&D Ireland
InventorsDeborah M. Schachter, Lieven Elvire Colette Baert, Guenter Kraus, Qiang Zhang, Iksoo Chun
Life of this patent
Estimating the term…
Loading patent…
AssigneeJanssen R&D Ireland
InventorsDeborah M. Schachter, Lieven Elvire Colette Baert, Guenter Kraus, Qiang Zhang, Iksoo Chun
Estimating the term…
A degradable, removable, pharmaceutical implant for the sustained release of one or more drugs in a subject, wherein the pharmaceutical implant is composed of a tube comprising an outer wall made of a degradable polymer completely surrounding a cavity, wherein the outer wall has a plurality of openings and wherein the cavity contains one or more sets of micro-particles, which micro-particles contain an active agent or a combination of two or more active agents, and wherein the size of the microparticles is selected such that the majority of the microparticles cannot pass through the openings.
A degradable, removable, pharmaceutical subcutaneous implant for the sustained release of one or more drugs in a subject, wherein the pharmaceutical implant is composed of a tube comprising an outer wall made of a degradable polymer completely surrounding a cavity, wherein the outer wall has a plurality of openings and wherein the cavity contains one or more sets of micro-particles, which micro-particles are embedded in a hydrogel and contain at least one drug selected from an HIV inhibitor or an HCV inhibitor, and wherein the size of the microparticles is selected such that the majority of the microparticles cannot pass through the openings.
Dependencies are inferred from the claim text.